Prosecution Insights
Last updated: April 19, 2026

Sinopsee Therapeutics

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17596988 COMPOUNDS FOR TREATMENT OF CANCER DAHLIN, HEATHER RAQUEL 1629 Final Rejection Dec 22, 2021
17596976 COMPOUNDS FOR TREATMENT OF EYE DISORDERS DAHLIN, HEATHER RAQUEL 1629 Final Rejection Dec 22, 2021

Managing Sinopsee Therapeutics's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month